Detalhe da pesquisa
1.
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504454
2.
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Am J Hematol
; 99(6): 1108-1118, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563187
3.
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood
; 137(25): 3495-3506, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598678
4.
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Blood
; 136(20): 2290-2295, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959052
5.
KMT2A-ARHGEF12, a therapy related fusion with poor prognosis.
Mol Biol Rep
; 48(10): 7021-7027, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383244
6.
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 179(3): 439-448, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770576
7.
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia.
Haematologica
; 107(6): 1454-1459, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788987
8.
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
Am J Hematol
; 96(9): E353-E356, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152612
9.
Autoimmune haemolytic anaemia associated with COVID-19 infection.
Br J Haematol
; 190(1): 29-31, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374906
10.
Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
Br J Haematol
; 186(1): 146-149, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548257
11.
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group.
Am J Hematol
; 94(7): E183-E185, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30945328
12.
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.
Blood Adv
; 6(1): 207-211, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844264
13.
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy.
Hemasphere
; 6(6): e716, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747848
14.
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia.
Blood Adv
; 6(12): 3655-3658, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290439
15.
Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review.
EJHaem
; 1(2): 601-603, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844981
16.
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.
J Clin Oncol
; 28(5): 808-14, 2010 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20048183